Fig 1: Loss of CD14 upregulates the frequency of CD301b+ macrophages in adipose tissue. (A) Representative images of tube formation (left) and total tube length (right) by bEND.3 cells conditioned with supernatant of epWAT-harvested SVFs. (B) Proliferation assay for bEND.3 cell. (C) The proportion of F4/80+CD11b+ macrophages in epWAT of HFD-fed mice. (D) Volcano plot and heatmap representing the differentially expressed gene level in Cd14−/− relative to WT mice. The data were generated from RNA deep sequencing as described. (E) RT-qPCR analysis for the relative mRNA abundance of CD301b in epWAT. Frequencies of (F) CD301b+, (G) CD206+, and CD11c+ ATMs in epWAT of HFD-fed mice. (H) The frequencies of CD301(CLEC10A)-positive ATMs in overweight/obese and healthy weight individuals. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 mean the significant difference between groups, and ns means not significant. epWAT, epididymal adipose tissue.
Fig 2: The proangiogenic potential of CD14lowCD301+ ATMs. (A, B) UMPA presentation of six monocyte/macrophage clusters in (A) human and (B) mice adipose tissues. Clusters were annotated manually based on their respective protein and mRNA expression profiles. (C–F) Expression of marker genes in each Mono/Mac cluster and constitutive share of CD14low CD301+ ATMs from (C, D) human and (E, F) mice. (G) Representative immunofluorescent images showed the expressions of CD31, CD301(Clec10a), CD68 in CD14high, and CD14low human AT sections and (H) of CD31, CD301b, F4/80 in WT, and Cd14−/− mice sections.
Fig 3: Cd14−/− BMDMs promote angiogenesis via secreting IGF-1. (A) Induction of BMDMs. Frequencies of (B) CD301b+ and (C) CD206+ cells in IL-4 (20 ng/ml) or LPS (100 ng/ml) conditioned BMDMs. (D) Cd301b mRNA responsiveness to IL-4. (E) IGF-1 concentration in supernatants of BMDMs. (F) Proliferation of bEND.3 cells conditioned with BMDMs supernatants. (G) Tube formation by bEND.3 cells conditioned with BMDMs supernatants. (H) Proliferation and (I) tube formation with or without IGF-1 Abs blockade. Scare bar: 100 μm. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 mean the significant difference between groups, and ns means not significant. LPS, lipopolysaccharide.
Fig 4: Cd14−/− ATMs facilitate angiogenesis by secreting IGF-1. (A) Pseudotime analysis reveals differentiation of CD301b+ ATM in vivo. Left: UMAP plots depicting the inferred diffusion pseudotime of CD14lowCD301bhigh Mac in ATMs. Right: relative expression of Cd301b, Igf1, Pdgf, and Vegf across pseudotime. (B) ELISA assay for the concentration of IGF-1 released by SVFs. (C) RT-qPCR analysis for Igf1 in epWAT (left), SVFs (middle), and adipocytes (right). (D) The concentration of IGF-1 in supernatants of WT and Cd14−/− ATMs. (E) Tube formation by bEND.3 cells conditioned with ATMs supernatant. Scare bar: 100 μm. ∗P < 0.05, ∗∗∗P < 0.001 mean the significant difference between groups, and ns means not significant. epWAT, epididymal adipose tissue.
Supplier Page from BioLegend for APC anti-mouse CD301b (MGL2)